FREDUN PHARMACEUTICALS
Back to All Ratios
|
FREDUN PHARMACEUTICALS Last 5 Year EBIT Growth History
[Consolidated]
| Mar2026 | Mar2025 | |
|---|---|---|
| EBIT Growth(%) | 73.08 | - |
What is the latest EBIT Growth ratio of FREDUN PHARMACEUTICALS ?
| Year | EBIT Growth |
|---|---|
| Mar2026 | 73.08 |
| Mar2025 | - |
How is EBIT Growth of FREDUN PHARMACEUTICALS Trending?
| Years | EBIT Growth | % Change | |
|---|---|---|---|
| Mar2026 | 73.08 | 0 | |
| Mar2025 | 0 | - | |
Other Financial Ratios of FREDUN PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,571.7 Cr | 10.8% | 23.7% | 238.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 10.8% |
23.7% |
238.3% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses